Lighthouse Investment Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Lighthouse Investment Partners’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-17,666	Closed	-$2.33M	–	721
2025 Q1	$2.33M	Buy	+17,666	New	+$2.2M	0.1%	243
2024 Q1	–	Sell	-62,450	Closed	-$4.47M	–	477
2023 Q4	$4.47M	Buy	+62,450	New	+$3.59M	0.2%	118

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lighthouse Investment Partners's ITCI Position: Q2 2025 in Review

Lighthouse Investment Partners sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 17,666 shares — an estimated $2.33M sold.

Lighthouse Investment Partners first reported a position in ITCI in Q4 2023 and held it in 2 quarters. The position peaked at $4.47M in Q4 2023. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Lighthouse Investment Partners reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Lighthouse Investment Partners sold 17,666 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $2.33M.
Lighthouse Investment Partners first reported a position in Intra-Cellular Therapies Inc. in Q4 2023 and held it in 2 quarters.
Lighthouse Investment Partners's Intra-Cellular Therapies Inc. position peaked at $4.47M in Q4 2023.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Lighthouse Investment Partners's 13F filing for Q2 2025, filed 14 Aug 2025.